Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection
- 11 September 2020
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 53 (2) , 587-596
Abstract
Background: Tumor stiffness (TS), measured by magnetic resonance elastography (MRE), could be associated with tumor mechanical properties and tumor grade.Purpose: To determine whether TS obtained using MRE is associated with survival in patients with single nodular hepatocellular carcinoma (HCC) after hepatic resection (HR).Study Type: Retrospective.Population: In all, 95 patients with pathologically confirmed HCCs.Field Strength/Sequence: 1.5T/3D spin‐echo echo‐planar imaging MRE.Assessment: TS values of the whole tumor (TS‐WT) and of a solid portion of the tumor (TS‐SP) after excluding the necrotic area were measured on stiffness maps. Known imaging prognostic factors of HCC were also analyzed. After surgery, pathologic findings were evaluated from resected pathology specimens.Statistical Tests: Fisher's exact test and the Mann–Whitney U‐test were performed to determine the significance of differences according to the tumor grade. Overall survival (OS) / recurrence‐free survival (RFS) analyses were performed using Kaplan–Meier analyses and Cox multivariable models.Results: The average TS‐WT was 2.14 ± 0.74 kPa, and the average TS‐SP was 2.51 ± 1.07 kPa. The cumulative incidence of RFS was 73.1%, 63.1%, and 57.3% at 1, 3, and 5 years, respectively. The TS‐WT, TS‐SP, and tumor size (≥5 cm) were significant prognostic factors for RFS (P < 0.001; P < 0.001; P = 0.017, respectively). The estimated overall 1‐, 3‐, and 5‐year survival rates were 95.7%, 86.9%, and 80.8%, respectively. The alpha‐fetoprotein changes, platelets, tumor size (≥5 cm), and vascular invasion in pathology were significant predictive factors for overall survival (all P < 0.05). Tumor necrosis, TS‐WT, TS‐SP, and vascular invasion in pathology were significantly correlated with poorly differentiated HCC (all P < 0.05).Data Conclusion: The TS‐WT, TW‐SP, and tumor size (≥5 cm) were significant predictive factors of RFS after HR in patients with HCC.Level of EvidenceTechnical Efficacy Stage 5J. MAGN. RESON. IMAGING 2021;53:587–596.Keywords
This publication has 40 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapyAbdominal Radiology, 2017
- Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applicationsProgress in Nuclear Magnetic Resonance Spectroscopy, 2015
- Adjuvant Therapy for Hepatocellular Carcinoma after Curative TreatmentDigestive Diseases, 2014
- Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year UpdateRadiology, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Magnetic Resonance Elastography of LiverMagnetic Resonance Imaging Clinics of North America, 2014
- Radiofrequency Ablation of Hepatocellular Carcinoma as First-Line Treatment: Long-term Results and Prognostic Factors in 162 Patients with CirrhosisRadiology, 2014
- Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgeryHepatology Research, 2013
- Review of MR elastography applications and recent developmentsJournal of Magnetic Resonance Imaging, 2012